Topical Gel for Erectile Dysfunction Gets FDA Approval for Over-the-Counter Sale
12 Jun 2023
Drug Approval
TUESDAY, June 13, 2023 -- Men with erectile dysfunction will now have the option of using a topical gel to treat the condition.
The U.S. Food and Drug Administration has approved over-the-counter marketing for the product, called Eroxon, as a first-of-its-kind medical product. The British pharmaceutical firm Futura Medical makes the gel.
“FDA set a very high standard in evaluating the effectiveness and safety of De Novo Medical Devices. I am delighted that we met this standard,” Futura CEO James Barder said in a news release on Monday.
About 30 million American men are affected by erectile dysfunction, where they’re not able to get or keep an erection for sexual activity.
This new gel will be sold in a single-dose tube, CNN reported.
It should be applied to the head of the penis before sex. Users may be able to become erect within 10 minutes and maintain that for long enough to have sex in about 65% of those who use it, according to the company.
The product is already sold in Belgium and the United Kingdom, where it costs the equivalent of $31.22 in U.S. dollars for a four-pack, CNN reported.
“We don’t have specific pricing details yet, as the pricing will ultimately be determined by the partner who launches Eroxon in the U.S.,” a company spokesman told CNN.
The timeline for when the product will be in the United States is unknown but it could be 2025, CNN reported.
Diseases such as type 2 diabetes can contribute to erectile dysfunction, as can certain medications, anxiety disorders, smoking, drinking excessive alcohol, being overweight or using illegal drugs.
Sources
Future Medical, news release, June 12, 2023
CNN
Posted June 2023
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.